We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




“Live” Cyberplasm Microbot Designed for Disease Detection

By LabMedica International staff writers
Posted on 11 Apr 2012
Print article
A “living” prototype microbot is under development that could someday identify diseases in humans.

Called Cyberplasm, it will combine advanced microelectronics with latest developments in biomimicry (technology inspired by nature). The goal is for Cyberplasm to have an electronic nervous system, “eye” and “nose” sensors derived from mammalian cells, as well as artificial muscles that utilize glucose as an energy source to propel it. The key purpose is to engineer and incorporate robot components that respond to light and chemicals in the same way as biologic systems. This is a totally new way of utilizing robotics technology.

Cyberplasm is being developed over the next few years as part of an international collaboration funded by the UK Engineering and Physical Sciences Research Council (EPSRC) and the US National Science Foundation (NSF; Arlington, VA, USA). The UK-based work is taking place at Newcastle University (UK). The project originated from a sandbox session on synthetic biology jointly funded by the two organizations.

Cyberplasm will be devised to mimic key functions of the sea lamprey, a creature found mostly in the Atlantic Ocean. It is believed this application will enable the microbot to be very sensitive and responsive to any environment into which it is placed. Future uses could include the ability to swim inconspicuously through the human body to detect a wide host of diseases.

The sea lamprey [Petromyzon marinus] has a very primitive nervous system, which is easier to mimic than more complicated nervous systems. This, combined with the fact that it swims, made the sea lamprey the best candidate for the scientists on which to base Cyberplasm.

Once it is developed, the Cyberplasm prototype will be less than 1-cm long. Future versions could possibly be less than 1-mm long or even constructed on a nanoscale. “Nothing matches a living creature’s natural ability to see and smell its environment and therefore to collect data on what's going on around it,” said bioengineer Dr. Daniel Frankel of Newcastle University, who is leading the UK-based work.

Cyberplasm’s sensors are being developed to respond to external stimuli by transforming them into electronic impulses that are sent to an electronic “brain” equipped with sophisticated microchips. This brain will then send electronic messages to artificial muscles instructing them how to contract and relax, enabling the robot to navigate its way safely using an undulating motion. Similarly, data on the chemical composition of the robot’s surroundings can be collected and stored via these systems for later recovery by the robot’s operators.

Cyberplasm could also represent the beginning of important advances in, for example, sophisticated prosthetics where living muscle tissue might be engineered to contract and relax in response to stimulation from light waves or electronic signals. “We’re currently developing and testing Cyberplasm’s individual components,” stated Daniel Frankel. “We hope to get to the assembly stage within a couple of years. We believe Cyberplasm could start being used in real-world situations within five years.”

The UK component of the Cyberplasm project is a three-year initiative that is receiving EPSRC funding of just over GBP 298,000. EPSRC is the main UK government agency for funding research and training in engineering and the physical sciences, investing more than GBP 800 million a year in a wide range of topics--from mathematics to materials science, and from information technology (IT) to structural engineering.

NSF is an independent US agency created by the US Congress in 1950. With an annual budget of approximately USD 6.9 billion (FY 2010), it is the funding source for about 20% of all federally-supported basic research conducted by US colleges and universities. In many fields, such as mathematics, computer science and the social sciences, NSF is the major source of federal backing.

Related Links:

UK Engineering and Physical Sciences Research Council
US National Science Foundation
Newcastle University


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.